-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
Regeneron Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from 2010 to 2023.
- Regeneron Pharmaceuticals, Inc. Interest Expense for the quarter ending March 31, 2024 was $16.1M, a 10.6% decline year-over-year.
- Regeneron Pharmaceuticals, Inc. Interest Expense for the twelve months ending March 31, 2024 was $71.1M, a 11.4% increase year-over-year.
- Regeneron Pharmaceuticals, Inc. annual Interest Expense for 2023 was $73M, a 22.9% increase from 2022.
- Regeneron Pharmaceuticals, Inc. annual Interest Expense for 2022 was $59.4M, a 3.67% increase from 2021.
- Regeneron Pharmaceuticals, Inc. annual Interest Expense for 2021 was $57.3M, a 0.7% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)